{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T02:37:08Z","timestamp":1777775828744,"version":"3.51.4"},"reference-count":26,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T00:00:00Z","timestamp":1620432000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Introduction.<\/jats:bold>\n                    Present study was performed to verify red blood cell distribution width-to-platelet ratio (RPR) level in rheumatoid arthritis (RA) patients and to examine its correlation with clinical and biochemical indicators of disease activity status.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods.<\/jats:bold>\n                    In this cross-sectional analytical study, 67 patients with RA and 34 age- and gender-matched healthy control subjects were enrolled. Based on the disease activity score 28-ESR (DAS28-ESR), RA patients were divided into subgroups: low disease activity (n = 20), moderate disease activity (n = 22) and high disease activity (n = 25). Laboratory tests included erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) concentration, platelet count (PLT), red blood cells count (RBC), red blood cells distribution width (RDW) and fibrinogen concentration. Statistical analyses were carried out using SPSS 13 software. Statistical significance was set at a p-value less than 0.05.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results.<\/jats:bold>\n                    There was statistically significant difference (p = 0.006) between RPR in RA patients with different stages of disease activity, with higher values in patients with low disease activity. The RPR showed statistically significant negative correlations with ESR (rho = \u20130.309; p = 0.012), CRP (rho = \u20130.421; p = 0.001), swollen joint count \u2013 SJC (rho = \u20130.368; p = 0.002) and tender joint count \u2013 TJC (rho = \u20130.355; p = 0.003), DAS28-ESR (rho = \u20130.409; p = 0.001), DAS28-CRP (rho = \u20130.422; p &lt; 0.0005) and Visual analogue scale \u2013 VAS (rho = \u20130.260; p = 0.033) in RA patients.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion.<\/jats:bold>\n                    The present study provided evidence that the lower RPR values in RA patients are significantly associated with the disease activity indicators.\n                  <\/jats:p>","DOI":"10.2478\/rjim-2020-0044","type":"journal-article","created":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T15:19:48Z","timestamp":1610291988000},"page":"180-186","source":"Crossref","is-referenced-by-count":3,"title":["Red blood cell distribution width-to-platelet ratio inversely correlates with indicators of disease activity status in rheumatoid arthritis patients"],"prefix":"10.2478","volume":"59","author":[{"given":"Amela","family":"Dervi\u0161evi\u0107","sequence":"first","affiliation":[{"name":"Department of Human Physiology, Faculty of Medicine , University of Sarajevo , Sarajevo , Bosnia and Herzegovina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amila","family":"Muhi\u0107","sequence":"additional","affiliation":[{"name":"Health Care Center Breza , Breza , Bosnia and Herzegovina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asija","family":"Za\u010diragi\u0107","sequence":"additional","affiliation":[{"name":"Department of Human Physiology, Faculty of Medicine , University of Sarajevo , Sarajevo , Bosnia and Herzegovina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Almir","family":"Fajki\u0107","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Faculty of Medicine , University of Sarajevo , Sarajevo , Bosnia and Herzegovina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lejla","family":"Dervi\u0161evi\u0107","sequence":"additional","affiliation":[{"name":"Department of Human Anatomy, Faculty of Medicine , University of Sarajevo , Sarajevo , Bosnia and Herzegovina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilvana","family":"Hasanbegovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Human Anatomy, Faculty of Medicine , University of Sarajevo , Sarajevo , Bosnia and Herzegovina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orhan","family":"Lepara","sequence":"additional","affiliation":[{"name":"Department of Human Physiology, Faculty of Medicine , University of Sarajevo , Sarajevo , Bosnia and Herzegovina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malik","family":"Galija\u0161evi\u0107","sequence":"additional","affiliation":[{"name":"University Clinic for Neuroradiology , Medical University Innsbruck , Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2021,5,8]]},"reference":[{"key":"2026042914151284940_j_rjim-2020-0044_ref_001_w2aab3b7c18b1b6b1ab1ab1Aa","doi-asserted-by":"crossref","unstructured":"1. SMYRNOVA G. The relationship between hemoglobin level and disease activity in patients with rheumatoid arthritis. Rev Bras Reumatol. 2014; 54:437\u2013440.10.1016\/j.rbr.2014.06.002","DOI":"10.1016\/j.rbre.2014.06.003"},{"key":"2026042914151284940_j_rjim-2020-0044_ref_002_w2aab3b7c18b1b6b1ab1ab2Aa","doi-asserted-by":"crossref","unstructured":"2. DAHLQVIST SR., NILSSON TK., NORBERG B. Thrombocytosis in active rheumatoid arthritis. Relation to other parameters of inflammatory activity and confounding effect of automated cell counting. Clinical rheumatology 1988; 7:335\u2013341.10.1007\/BF02239189","DOI":"10.1007\/BF02239189"},{"key":"2026042914151284940_j_rjim-2020-0044_ref_003_w2aab3b7c18b1b6b1ab1ab3Aa","doi-asserted-by":"crossref","unstructured":"3. HABETS KL., TROUW LA., LEVARHT EW., KORPORAAL SJ., HABETS PA., DE GROOT P., et al. Anti-citrullinated protein antibodies contribute to platelet activation in rheumatoid arthritis. Arthritis Res Ther. 2015; 17:209.10.1186\/s13075-015-0665-7","DOI":"10.1186\/s13075-015-0665-7"},{"key":"2026042914151284940_j_rjim-2020-0044_ref_004_w2aab3b7c18b1b6b1ab1ab4Aa","doi-asserted-by":"crossref","unstructured":"4. ALLEN LA., FELKER GM., MEHRA MR., CHIONG JR., DUNLAP SH., GHALI JK., et al. Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure. J Card Fail 2010; 1(3):230\u2013238.","DOI":"10.1016\/j.cardfail.2009.11.003"},{"key":"2026042914151284940_j_rjim-2020-0044_ref_005_w2aab3b7c18b1b6b1ab1ab5Aa","doi-asserted-by":"crossref","unstructured":"5. AKSOY S\u00b8N., SAVAS\u00b8 E., SUCU M., KISACIK B., KUL S., ZENGIN O. Association between red blood cell distribution width and disease activity in patients with Beh\u00c7et\u2019s disease. J Int Med Res. 2015; 43:765\u2013773.10.1177\/0300060515591063","DOI":"10.1177\/0300060515591063"},{"key":"2026042914151284940_j_rjim-2020-0044_ref_006_w2aab3b7c18b1b6b1ab1ab6Aa","doi-asserted-by":"crossref","unstructured":"6. CETINKAYA E., SENOL K., SAYLAM B., TEZ M. Red cell distribution width to platelet ratio: new and promising prognostic marker in acute pancreatitis. World J Gastroenterol 2014; 20:14450\u201314454.10.3748\/wjg.v20.i39.14450","DOI":"10.3748\/wjg.v20.i39.14450"},{"key":"2026042914151284940_j_rjim-2020-0044_ref_007_w2aab3b7c18b1b6b1ab1ab7Aa","doi-asserted-by":"crossref","unstructured":"7. TAEFI A., HUANG CC., KOLLI K., EBRAHIMI S., PATEL M. Red cell distribution width to platelet ratio, a useful indicator of liver fibrosis in chronic hepatitis patients. Hepatol Int 2015; 9:454\u2013460.10.1007\/s12072-015-9638-9","DOI":"10.1007\/s12072-015-9638-9"},{"key":"2026042914151284940_j_rjim-2020-0044_ref_008_w2aab3b7c18b1b6b1ab1ab8Aa","doi-asserted-by":"crossref","unstructured":"8. ALETAHA D., NEOGI T., SILMAN AJ., FUNOVITS J., FELSON D., BINGHAM CO., et al. Rheumatoid arthritis classification criteria. An American Colege of Rheumatology \/European League Against Rheumatism Collaborative Initiative. Ann. Rheum. Dis. 2010; 69:1580\u20131588.","DOI":"10.1136\/ard.2010.138461"},{"key":"2026042914151284940_j_rjim-2020-0044_ref_009_w2aab3b7c18b1b6b1ab1ab9Aa","doi-asserted-by":"crossref","unstructured":"9. CARLSSON AM. Assessment of chronic pain. Pain. 1983; 16(1):87\u2013101.10.1016\/0304-3959(83)90088-X","DOI":"10.1016\/0304-3959(83)90088-X"},{"key":"2026042914151284940_j_rjim-2020-0044_ref_010_w2aab3b7c18b1b6b1ab1ac10Aa","doi-asserted-by":"crossref","unstructured":"10. WELLS G., BECKER JC., TENG J., DOUGADOS M., SCHIFF M., SMOLEN J., et al. Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann Rheum Dis. 2009; 68(6):954\u2013960.10.1136\/ard.2007.084459267454718490431","DOI":"10.1136\/ard.2007.084459"},{"key":"2026042914151284940_j_rjim-2020-0044_ref_011_w2aab3b7c18b1b6b1ab1ac11Aa","doi-asserted-by":"crossref","unstructured":"11. CHEN B., YE B., ZHANG J., YING L., CHEN Y. RDW to platelet ratio: a novel noninvasive index for predicting hepatic fibrosis and cirrhosis in chronic hepatitis B. PLoS ONE 2013; 8:e68780.10.1371\/journal.pone.0068780371429323874760","DOI":"10.1371\/journal.pone.0068780"},{"key":"2026042914151284940_j_rjim-2020-0044_ref_012_w2aab3b7c18b1b6b1ab1ac12Aa","doi-asserted-by":"crossref","unstructured":"12. ARVIDSON NG., LARSSON A., LARSEN A. Disease activity in rheumatoid arthritis: fibrinogen is superior to the erythrocyte sedimentation rate. Scand J Clin Lab Invest 2002; 62(4):315\u2013319.10.1080\/00365510276014588912476931","DOI":"10.1080\/003655102760145889"},{"key":"2026042914151284940_j_rjim-2020-0044_ref_013_w2aab3b7c18b1b6b1ab1ac13Aa","doi-asserted-by":"crossref","unstructured":"13. KLIMENTA B., NEFIC H., PRODANOVIC N., JADRIC R., HUKIC F. Association of biomarkers of inflammation and HLA-DRB1 gene locus with risk of developing rheumatoid arthritis in females. Rheumatol Int Rheumatol Int. 2019; 39(12):2147\u20132157.10.1007\/s00296-019-04429-y","DOI":"10.1007\/s00296-019-04429-y"},{"key":"2026042914151284940_j_rjim-2020-0044_ref_014_w2aab3b7c18b1b6b1ab1ac14Aa","unstructured":"14. YILDIRIM K., KARATAY S., MELIKOGLU MA., GURESER G., UGUR M., SENEL K. Associations between acute phase reactant levels and disease activity score (DAS28) in patients with rheumatoid arthritis. Ann Clin Lab Sci. 2004; 34:423\u2013426."},{"key":"2026042914151284940_j_rjim-2020-0044_ref_015_w2aab3b7c18b1b6b1ab1ac15Aa","doi-asserted-by":"crossref","unstructured":"15. LOURO MO., COCHO JA., MERA A., TUTOR JC. Immunochemical and enzymatic study of ceruloplasmin in rheumatoid arthritis. J Trace Elements Med Biol. 2000; 14:174\u2013178.10.1016\/S0946-672X(00)80007-3","DOI":"10.1016\/S0946-672X(00)80007-3"},{"key":"2026042914151284940_j_rjim-2020-0044_ref_016_w2aab3b7c18b1b6b1ab1ac16Aa","doi-asserted-by":"crossref","unstructured":"16. BOWMAN SJ. Hematological manifestations of rheumatoid arthritis. Scan J Rheumatol 2002; 31:251\u2013259.10.1080\/03009740276037512412455813","DOI":"10.1080\/030097402760375124"},{"key":"2026042914151284940_j_rjim-2020-0044_ref_017_w2aab3b7c18b1b6b1ab1ac17Aa","doi-asserted-by":"crossref","unstructured":"17. JAGROOP IA., KAKAFIKA AI., MIKHAILIDIS DP. Platelets and vascular risk: an option for treatment. Curr Pharm Des 2007; 13:1669\u20131683.10.2174\/13816120778083138317584097","DOI":"10.2174\/138161207780831383"},{"key":"2026042914151284940_j_rjim-2020-0044_ref_018_w2aab3b7c18b1b6b1ab1ac18Aa","doi-asserted-by":"crossref","unstructured":"18. STOKES KY., GRANGER DN. Platelets: A critical link between inflammation and microvascular dysfunction. J Physiol 2012; 590:1023\u20131034.10.1113\/jphysiol.2011.225417338181022183721","DOI":"10.1113\/jphysiol.2011.225417"},{"key":"2026042914151284940_j_rjim-2020-0044_ref_019_w2aab3b7c18b1b6b1ab1ac19Aa","doi-asserted-by":"crossref","unstructured":"19. LU A., ZHA Q. Correlations among cartilage erosion, IgA level, red blood cell and platelet counts in 436 rheumatoid arthritis patients with path analysis. 2009 3rd International Conference on Bioinformatics and Biomedical Engineering. 2009:1\u20133.10.1109\/ICBBE.2009.5162561","DOI":"10.1109\/ICBBE.2009.5162561"},{"key":"2026042914151284940_j_rjim-2020-0044_ref_020_w2aab3b7c18b1b6b1ab1ac20Aa","doi-asserted-by":"crossref","unstructured":"20. AYYILDIZ H., KARABULUT N., KALAYCI M. Relationship between red blood cell distribution width and schizophrenia. Int J Med Biochem 2018; 1(1):15\u201319.","DOI":"10.14744\/ijmb.2017.32042"},{"key":"2026042914151284940_j_rjim-2020-0044_ref_021_w2aab3b7c18b1b6b1ab1ac21Aa","unstructured":"21. CAKIR L., AKTAS G., MERCIMEK OB., ENGINYURT O., KAYA Y., MERCIMEK K. Are red cell distribution width and mean platelet volume associated with rheumatoid arthritis? Biomed Res. 2016; 27(2):292\u2013294."},{"key":"2026042914151284940_j_rjim-2020-0044_ref_022_w2aab3b7c18b1b6b1ab1ac22Aa","doi-asserted-by":"crossref","unstructured":"22. KARNAD A., POSKITT TR. The automated complete blood cell count. Use of the red blood cell volume distribution width and mean platelet volume in evaluating anemia and thrombocytopenia. Arch Intern Med 1985; 145:1270\u20131272.10.1001\/archinte.1985.00360070150025","DOI":"10.1001\/archinte.1985.00360070150025"},{"key":"2026042914151284940_j_rjim-2020-0044_ref_023_w2aab3b7c18b1b6b1ab1ac23Aa","doi-asserted-by":"crossref","unstructured":"23. THOMPSON WG., MEOLA T., LIPKIN M JR., FREEDMAN ML. Red cell distribution width, mean corpuscular volume, and transferrin saturation in the diagnosis of iron deficiency. Arch Intern Med 1988; 148:2128\u20132130.10.1001\/archinte.1988.00380100026006","DOI":"10.1001\/archinte.1988.00380100026006"},{"key":"2026042914151284940_j_rjim-2020-0044_ref_024_w2aab3b7c18b1b6b1ab1ac24Aa","doi-asserted-by":"crossref","unstructured":"24. LEE WS., KIM TY. Relation between red blood cell distribution width and inflammatory biomarkers in rheumatoid arthritis. Arch Pathol Lab Med 2010; 134:505\u2013506.10.5858\/134.4.505.c20367302","DOI":"10.5858\/134.4.505.c"},{"key":"2026042914151284940_j_rjim-2020-0044_ref_025_w2aab3b7c18b1b6b1ab1ac25Aa","doi-asserted-by":"crossref","unstructured":"25. RODR\u00cdGUEZ-CARRIO J., ALPERI-L\u00d3PEZ M., L\u00d3PEZ P., ALONSO-CASTRO S., BALLINA-GARC\u00cdA FJ., SU\u00c1REZ A. Red cell distribution width is associated with cardiovascular risk and disease parameters in rheumatoid arthritis. Rheumatology (Oxford) 2015; 54:641\u2013646.10.1093\/rheumatology\/keu34525239880","DOI":"10.1093\/rheumatology\/keu345"},{"key":"2026042914151284940_j_rjim-2020-0044_ref_026_w2aab3b7c18b1b6b1ab1ac26Aa","doi-asserted-by":"crossref","unstructured":"26. LOU Y., WANG M., MAO W. Clinical usefulness of measuring red blood cell distribution width in patients with hepatitis B. PloS One 2012; 7:e37644.10.1371\/journal.pone.0037644335928922649548","DOI":"10.1371\/journal.pone.0037644"}],"container-title":["Romanian Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/content.sciendo.com\/view\/journals\/rjim\/ahead-of-print\/article-10.2478-rjim-2020-0044\/article-10.2478-rjim-2020-0044.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/rjim-2020-0044","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:16:44Z","timestamp":1777486604000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/rjim-2020-0044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,8]]},"references-count":26,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,5,8]]},"published-print":{"date-parts":[[2021,6,1]]}},"alternative-id":["10.2478\/rjim-2020-0044"],"URL":"https:\/\/doi.org\/10.2478\/rjim-2020-0044","relation":{},"ISSN":["2501-062X"],"issn-type":[{"value":"2501-062X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,8]]}}}